After Brexit, the impact on the life sciences and healthcare sectors is largely...
Pharmaceutical Challenges Aided by Laboratory Powder X-ray Diffraction
This white paper explores a number of ways that today's modern, laboratory-based powder x-ray diffraction (PXRD) instrumentation and advanced software can greatly assist pharmaceutical scientists in their quest to develop high-quality, stable products and accelerate their speed-to-market.
Trehalose: A Powerful Excipient in the Formulation Toolbox
In the pharmaceutical industry, products that benefit from the stabilising effects of trehalose include, but are not limited to, monoclonal antibodies (mAbs), antibody drug conjugates (ADCs), fusion proteins, peptides, stem cells and vaccines.
Brexit’s impact on UK life sciences: some key points
After Brexit, the impact on the life sciences and healthcare sectors is largely dependent on what model the UK adopts for its relationship with the EU.
Aqueous Cleaning in Pharmaceutical Manufacturing
The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefits in terms of effectiveness, minimal surface residue, and easier cleaning validation.
Lilly teams up with AC Immune for Alzheimer’s drug
Eli Lilly has signed a licence and collaboration agreement with Swiss biotech AC Immune for the research and development of tau aggregation inhibitor small molecules to treat neurodegenerative disorders, including Alzheimer’s disease.
NIH to support HIV care and prevention research in the US
The National Institute of Allergy and Infectious Diseases (NIAID), a National Institutes of Health (NIH) division, has announced plans to fund HIV care and prevention research in the southern US.
GARDP, Eisai and Takeda join forces to identify new antibiotics
The Global Antibiotic Research and Development Partnership (GARDP) in Switzerland has partnered with Eisai and Takeda Pharmaceutical in a bid to discover new antibiotics.
Vect-Horus and Janssen partner for neurodegenerative disease treatment
Vect-Horus has entered a research collaboration agreement with Johnson & Johnson subsidiary Janssen Pharmaceuticals for treating neurodegenerative diseases.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.